VeriMomHamilelikte dipropylene glycol salicylate kullanmaktan kaçınmalı mıyım? | VeriMom
No evidence of a harmonised CLP H360 or an EU Annex II/III restriction for dipropylene glycol salicylate was found (no EU ban/restriction). Several safety sources treat it as an ester of salicylic acid; the CIR assessment of salicylic acid/salicylates and government reviews report reproductive/developmental effects only at relatively high systemic doses in animals, not from topical cosmetic use. Some SDSs list H361 but these appear to be company self-classifications rather than a harmonised ECHA classification. Given the structural link to salicylic acid (structural/class-based concern) but absence of harmonised classification or robust reproductive studies on this exact compound, I assign a conservative h=1 (structural/class concern), m=1 (theoretical/mechanistic plausibility via ester → salicylate), e=1 (low but measurable dermal exposure for typical cosmetic use). Sources: PubChem, CIR salicylates review, Canada draft screening (salicylates), EWG, manufacturer/SDS notes.
ECHA regulatory hazard statements
- •H361
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- dipropylene glycol salicylate hamilelikte güvenli mi?
- No evidence of a harmonised CLP H360 or an EU Annex II/III restriction for dipropylene glycol salicylate was found (no EU ban/restriction). Several safety sources treat it as an ester of salicylic acid; the CIR assessment of salicylic acid/salicylates and government reviews report reproductive/developmental effects only at relatively high systemic doses in animals, not from topical cosmetic use. Some SDSs list H361 but these appear to be company self-classifications rather than a harmonised ECHA classification. Given the structural link to salicylic acid (structural/class-based concern) but absence of harmonised classification or robust reproductive studies on this exact compound, I assign a conservative h=1 (structural/class concern), m=1 (theoretical/mechanistic plausibility via ester → salicylate), e=1 (low but measurable dermal exposure for typical cosmetic use). Sources: PubChem, CIR salicylates review, Canada draft screening (salicylates), EWG, manufacturer/SDS notes.
- dipropylene glycol salicylate emzirirken güvenli mi?
- Same rationale as pregnancy: no direct harmonised reproductive classification or authoritative restriction for this specific ester, but it is an ester of salicylic acid which can be systemically active after absorption/hydrolysis. Dermal cosmetic use is expected to give low but measurable maternal systemic exposure in normal use; transfer into breastmilk would be contingent on maternal systemic levels. Conservative approach: same scores as pregnancy.
- dipropylene glycol salicylate bebek cildi için güvenli mi?
- Hazard (h) and mechanism (m) unchanged — no infant-specific reproductive/developmental data; however exposure (e) increased by +1 because infant skin (0–3 y) has higher surface-area-to-body-weight and an immature barrier, so measured dermal absorption for the parent compound would translate to higher internal exposure in infants. There is no evidence that infant topical use has produced harm for this specific ingredient, but prudence supports increased exposure score for baby skin.
- VeriMom dipropylene glycol salicylate nasıl puanlıyor?
- VeriMom dipropylene glycol salicylate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 27/100 (yüksek risk) olarak puanlar.
- Hamilelikte dipropylene glycol salicylate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.